Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment

Sabah Nisar1, Parvaiz Yousuf2, Tariq Masoodi3

  • 1Molecular and Metabolic Imaging Laboratory, Cancer Research Department, Sidra Medicine, Doha 26999, Qatar.

Insights

This review explores how cytokines and chemokines in the head and neck squamous cell carcinoma (HNSCC) tumor micro-environment drive aggressive cancer phenotypes. Understanding these signaling networks is crucial for improving HNSCC patient outcomes.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Head and neck squamous cell carcinomas (HNSCC) are aggressive cancers with poor prognoses.
  • Limited improvement in HNSCC survival rates necessitates a deeper understanding of cancer biology.
  • The tumor micro-environment (TME) significantly influences HNSCC development and progression.

Purpose of the Study:

  • To review the current knowledge of cytokine and chemokine networks within the HNSCC TME.
  • To elucidate the role of these networks in promoting cancer hallmarks.
  • To understand their contribution to tumor progression, metastasis, and therapeutic resistance.

Main Methods:

  • Comprehensive literature review of studies on HNSCC tumor micro-environment.
  • Analysis of cytokine and chemokine roles in cancer signaling pathways.
  • Synthesis of information on TME components influencing HNSCC hallmarks.

Main Results:

  • Cytokine and chemokine networks are integral to the HNSCC TME.
  • These networks regulate key cancer hallmarks like invasion, metastasis, and immune evasion.
  • Alterations in the TME promote an aggressive HNSCC phenotype and therapeutic resistance.

Conclusions:

  • Cytokine and chemokine signaling critically impacts HNSCC progression and aggressiveness.
  • Targeting these networks in the TME may offer novel therapeutic strategies for HNSCC.
  • Further research into HNSCC TME biology is essential for improving patient survival.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
322
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.6K